CAJ | 학술논문

目的：了解铜绿假单胞菌的医院感染现状及其耐药性变化，为临床防治提供依据。方法分析2008～2011年铜绿假单胞菌医院感染病例；统计分2008～2011年铜绿假单胞菌的耐药性变化。结果铜绿假单胞菌感染主要发生在重症监护病房（24.9％）和呼吸内科（17.0％）；感染部位主要是呼吸系统（76.9％）和创口（16.0％），亚胺培南、哌拉西林/他唑巴坦和头孢他啶连续4年耐药率均＜14％。结论危重患者是铜绿假单胞菌感染的易感人群；加强耐药性监测，合理应用抗菌药物十分重要。
목적：료해동록가단포균적의원감염현상급기내약성변화，위림상방치제공의거。방법분석2008～2011년동록가단포균의원감염병례；통계분2008～2011년동록가단포균적내약성변화。결과동록가단포균감염주요발생재중증감호병방（24.9％）화호흡내과（17.0％）；감염부위주요시호흡계통（76.9％）화창구（16.0％），아알배남、고랍서림/타서파탄화두포타정련속4년내약솔균＜14％。결론위중환자시동록가단포균감염적역감인군；가강내약성감측，합리응용항균약물십분중요。
Objective To investigate the information about the present nosocomial infection characteristics and drug resistance of Pseudomonas aeruginosa ( PA).Methods Nosocomial infection caused by PA was retrospectively analyzed during 2008-2011.The change in drug resistance of PA was analyzed during 2008-2011.Results The main depart-ments wi th nosocomial infection caused by PA happened frequently were intensive care units ( 24.9%) and respiration department(17.0%).The common sites were respiratory tract (76.9%) and wound (16%).The ratio of resistance for imipenem,piperacillin/tazobactam,ceftazidime against PA was less than 14%.Conclusions The acquired nosocomial infection caused by PA in critical patients more easily than in others.It is very important to select antibiotics correctly ac-cording to the results of susceptibility tests.